Caplight Directory>Companies>Resilient Biotics-preview>Resilientbiotics


Resilient Biotics

Resilient Biotics

Private
Durham, North CarolinaN/Ahttps://resilientbiotics.com/

Last Round

Series A

Jan 29, 2021

Total Funding Raised

$7.1M

Momentum Score

25 /100

Company Overview

Resilient Biotics is a biotechnology company developing live biotherapeutics to combat complex respiratory infections in human and animal health.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resilient Biotics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Resilient Biotics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 29, 2021
AcceleratorFeb 9, 2017
View all Funding Rounds

Key People

Founding team and executive leadership

Rachelle Galvin

President And CEO

Executive Team

Resilient Biotics Investors

Notable investors and investment history

InvestorRounds
Innovation In MotionSeries A
Fulcrum Global CapitalSeries A
Berkeley Catalyst FundSeries A
Viking Global InvestorsSeries A
ElancoSeries A
Illumina AcceleratorAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 863% MoM, reaching 867.

  • Jan 1, 2026

    Monthly visitors grew 268% MoM, from 90 to 331.

View all signals

Resilient Biotics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Resilient Biotics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Resilient Biotics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range10
Year Founded2017
Last FundingJan 29, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.